✦ LIBER ✦

Lamivudine is not effective in the treatment of non-cirrhotic HBeAg (−) chronic hepatitis B patients with low level viremia

✍ Scribed by Hakan Bozkaya; Cihan Yurdaydin; Mithat Bozdayi; Armagan Kocer Sagiroglu; Ozlem Erkan; Ozden Uzunalimoglu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of lamivudin

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Effect of lamivudine treatment in patien

✍ Nikolaos Nikolaidis; Themistoklis Vassiliadis; Olga Giouleme; Konstantinos Tziom 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Interferon alpha2a in combination with l

✍ Maria Raptopoulou-Gigi; Emanuel Sinakos; Helen Orphanou; Thalia Lalla 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Long-term effect of lamivudine treatment

✍ S.P. Hong; K.-H. Han; S.H. Ahn; Y.H. Paik; K.S. Lee; C.Y. Chon; Y.M. Moon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Changes in serum hepatitis B e antigen (

✍ Yi-Hao Yen; Sheng-Nan Lu; Chien-Hung Chen; Jing-Houng Wang; Chun-Mei Wu; Chao-Hu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Correlation of the occurrence of YMDD mu

✍ Feng Wu; Min-Jin Wu; Xiao-Lin Zhuge; Shao-Ming Zhu; Biao Zhu 📂 Article 📅 2012 🏛 Zhejiang University School of Medicine, China 🌐 English ⚖ 111 KB